NP Life Sciences Health Industry Group Inc. Increase (Decrease) in Accounts Payable
NP Life Sciences Health Industry Group Inc. (ACAT) reported Increase (Decrease) in Accounts Payable of -$105 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2024-04-16
- NP Life Sciences Health Industry Group Inc. increase (decrease) in accounts payable for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- NP Life Sciences Health Industry Group Inc. increase (decrease) in accounts payable for the quarter ending 2023-06-30 was $0.00.
- NP Life Sciences Health Industry Group Inc. increase (decrease) in accounts payable for the quarter ending 2023-03-31 was -$105.00.
- NP Life Sciences Health Industry Group Inc. increase (decrease) in accounts payable for the quarter ending 2022-12-31 was -$3.10K.
- NP Life Sciences Health Industry Group Inc. increase (decrease) in accounts payable for fiscal 2022 was $6.13K.
- NP Life Sciences Health Industry Group Inc. increase (decrease) in accounts payable for fiscal 2020 was -$1.03K, a 282.48% decline from fiscal 2019.
- NP Life Sciences Health Industry Group Inc. increase (decrease) in accounts payable for fiscal 2019 was $565.00.
| Period end | Increase (Decrease) in Accounts Payable 0 month | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | -$105.00 10-Q · filed 2023-11-14 | -$3.20K derived: sum of 4 quarters · filed 2024-04-16 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$105.00 10-Q · filed 2023-08-14 | -$3.20K derived: sum of 3 quarters · filed 2024-04-16 | $2.50K derived: sum of 4 quarters · filed 2024-04-16 | |
| 2023-03-31 | -$105.00 10-Q · filed 2023-05-15 | -$3.20K derived: sum of 2 quarters · filed 2024-04-16 | $2.50K derived: sum of 3 quarters · filed 2024-04-16 | ||
| 2022-12-31 | -$3.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $2.60K derived: sum of 2 quarters · filed 2024-04-16 | $6.13K 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $5.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $9.23K 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | $3.53K 10-Q · filed 2023-08-14 | ||||
| 2020-12-31 | -$1.03K 10-K · filed 2022-04-15 | ||||
| 2019-12-31 | -$2.46K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | $798.00 derived: sum of 2 quarters · filed 2021-04-15 | -$9.26K derived: sum of 3 quarters · filed 2021-04-15 | $565.00 10-K · filed 2021-04-15 | |
| 2019-09-30 | $3.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$6.79K derived: sum of 2 quarters · filed 2020-11-16 | $3.03K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | -$10.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$233.00 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | $9.82K 10-Q · filed 2020-05-15 | ||||
| 2018-12-31 | $466.00 10-K · filed 2020-03-30 |